ArticleOncogene2023
Diosmetin suppresses the progression of ESCC by CDK2/Rb/E2F2/RRM2 pathway and synergies with cisplatin.
Yihuan Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleOncogene2023
Yihuan Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.